Bank Of New York Mellon Corp Albireo Pharma, Inc. Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$18.01 - $23.78 $1.56 Million - $2.06 Million	86,496 New	86,496 $1.87 Million
Q3 2022 Nov 14, 2022	SELL	$16.32 - $26.37 $22,880 - $36,970	-1,402 Reduced 1.61%	85,722 $1.66 Million
Q2 2022 Aug 15, 2022	SELL	$18.54 - $37.29 $175,091 - $352,166	-9,444 Reduced 9.78%	87,124 $1.73 Million
Q1 2022 May 11, 2022	BUY	$23.94 - $33.74 $301,644 - $425,124	12,600 Added 15.01%	96,568 $2.88 Million
Q4 2021 Feb 11, 2022	SELL	$21.19 - $31.29 $8,221 - $12,140	-388 Reduced 0.46%	83,968 $1.96 Million
Q3 2021 Nov 12, 2021	BUY	$27.36 - $35.98 $114,857 - $151,044	4,198 Added 5.24%	84,356 $2.63 Million
Q2 2021 Aug 11, 2021	SELL	$28.9 - $36.87 $368,879 - $470,608	-12,764 Reduced 13.74%	80,158 $2.82 Million
Q1 2021 May 13, 2021	BUY	$32.03 - $42.85 $393,744 - $526,755	12,293 Added 15.25%	92,922 $3.28 Million
Q4 2020 Feb 09, 2021	BUY	$31.56 - $42.16 $871,592 - $1.16 Million	27,617 Added 52.1%	80,629 $3.02 Million
Q3 2020 Nov 12, 2020	SELL	$23.19 - $41.61 $26,854 - $48,184	-1,158 Reduced 2.14%	53,012 $1.77 Million
Q2 2020 Aug 12, 2020	BUY	$14.82 - $29.92 $139,693 - $282,025	9,426 Added 21.07%	54,170 $1.43 Million
Q1 2020 May 06, 2020	BUY	$11.67 - $27.23 $98,366 - $229,521	8,429 Added 23.21%	44,744 $732,000
Q4 2019 Feb 14, 2020	BUY	$16.92 - $28.96 $46,530 - $79,640	2,750 Added 8.19%	36,315 $923,000
Q3 2019 Nov 07, 2019	BUY	$20.0 - $31.88 $29,460 - $46,959	1,473 Added 4.59%	33,565 $671,000
Q2 2019 Aug 12, 2019	SELL	$30.67 - $37.86 $177,763 - $219,436	-5,796 Reduced 15.3%	32,092 $1.04 Million
Q1 2019 May 14, 2019	BUY	$22.22 - $32.21 $7,465 - $10,822	336 Added 0.89%	37,888 $1.22 Million
Q4 2018 Feb 11, 2019	BUY	$20.9 - $32.57 $52,856 - $82,369	2,529 Added 7.22%	37,552 $921,000
Q3 2018 Nov 09, 2018	BUY	$29.29 - $36.87 $80,840 - $101,761	2,760 Added 8.55%	35,023 $0
Q2 2018 Aug 06, 2018	BUY	$28.9 - $37.31 $626,696 - $809,067	21,685 Added 205.0%	32,263 $1.15 Million
Q1 2018 May 15, 2018	BUY	$26.78 - $39.35 $57,309 - $84,209	2,140 Added 25.36%	10,578 $345,000
Q4 2017 Feb 09, 2018	BUY	$21.56 - $28.14 $181,923 - $237,445	8,438	8,438 $216,000

Others Institutions Holding ALBO

# of Institutions

Shares Held

865

Call Options Held

Put Options Held

View Full List

About ALBIREO PHARMA, INC.

Ticker ALBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,612,500
Description
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...

More about ALBO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account